Licensing of ASCs with TNF and/or IFNγ was reported to enhance the immunosuppressive functions of these cells, including inhibition of T cell proliferation [60, 61], which is in line with present results concerning HD/ASCs. This evidence concerns the gene IFNG and Huntington disease.